IPHA
Innate Pharma·NASDAQ
--
--(--)
--
--(--)
IPHA fundamentals
Innate Pharma (IPHA) released its earnings on Mar 26, 2026: revenue was 5.70M (YoY --), met estimates; EPS was -0.3492 (YoY --), met estimates.
Revenue / YoY
5.70M
--
EPS / YoY
-0.3492
--
Report date
Mar 26, 2026
IPHA Earnings Call Summary for Q4,2025
- Strategic Focus: Three assets (IPH4502, lacutamab, monalizumab) drive growth, with phase III trials for lacutamab (H2 2026) and monalizumab (data H2 2026).
- Financial Strength: EUR 44.8M cash, funding until Q3 2026; AstraZeneca partnerships worth up to $2.16B in milestones.
- Clinical Progress: IPH4502 shows activity in post-PADCEV bladder cancer; lacutamab trial design finalized for CTCL.
- Partnership Updates: MATISSE trial interim data at AACR; lacutamab financing discussions prioritize shareholder value.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Innate Pharma (IPHA) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Innate Pharma (IPHA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Innate Pharma (IPHA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Innate Pharma (IPHA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Innate Pharma (IPHA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Innate Pharma (IPHA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Innate Pharma's management provide for the next earnings period?What were the key takeaways from Innate Pharma's earnings call?What does Innate Pharma do and what are its main business segments?What is the market's earnings forecast for Innate Pharma next quarter?What is Innate Pharma's latest dividend and current dividend yield?What factors drove the changes in Innate Pharma's revenue and profit?What were the key takeaways from Innate Pharma’s earnings call?What is the revenue and EPS growth rate for Innate Pharma year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
